Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytruda's 2028 LOE nears.

High-dose radiation with Keytruda led to increased infiltration of various immune cells and formation of tertiary lymphoid ...

Zydus Lifesciences Limited (including its subsidiaries and affiliates), an innovation-led life-sciences company, with an ...

Licensing partner Zydus brings extensive commercial experience, marketing more than 225 FDA-approved medicines, providing a ...

After a long hiatus, why are the bulls so willing to buy in now?

The company is finding ways to overcome the headwinds it will encounter in the medium term.

Ahmedabad: Zydus Lifesciences Limited, a life-sciences company, with an international presence, has announced that its wholly ...

Formycon will develop, register, manufacture, and supply the product, while Zydus will be responsible for commercialization.

Formycon AG will be responsible for the development, registration, manufacture and supply of the product. Zydus Lifesciences ...

Under the terms of this agreement, Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the ...

MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS ...